Status:
NOT_YET_RECRUITING
Prognostic Impacts of Lipid Profile and BMI in Adult AML
Lead Sponsor:
Assiut University
Conditions:
AML (Acute Myeloid Leukemia)
BMI
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to evaluate the changes in lipid profile parameters (total cholesterol, triglycerides, HDL-C, and LDL-C) in adult AML patients before and after intensive induct...
Detailed Description
Acute Myeloid Leukemia is a heterogeneous hematological malignancy characterized by clonal proliferation and accumulation of immature myeloid cells in the bone marrow and peripheral blood. It predomin...
Eligibility Criteria
Inclusion
- Adult patients (≥18yearsold) newly diagnosed with AML.
- Patients eligible for intensive induction chemotherapy.
- Patients who have given informed consent to participate in the study.
Exclusion
- Patients with secondary or relapsed AML.
- Patients currently using lipid-lowering medications (e.g., statins).
- Patients with known endocrine or metabolic disorders affecting BMI or lipid profile (e.g., uncontrolled diabetes, hypothyroidism, Cushing's syndrome).
- Pregnant or lactating women.
- Patients unwilling or unable to complete the study protocol.
- Patients with M3 subtype of AML.
Key Trial Info
Start Date :
November 15 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 15 2027
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT07143877
Start Date
November 15 2025
End Date
March 15 2027
Last Update
August 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university Hospitals
Asyut, Asyut Governorate, Egypt, 71511